How and where to order Haloperidol (Haldol) 1.5 mg, 5 mg, 10 mg tablets or capsules online:
|Prices:||from $1.42 per pill
|Discount:||10% coupon: hf-5478
|Forms:||Haldol (Haloperidol) 1.5 mg, 5 mg, 10 mg tablets
|Type:||Haloperidol brand, Haldol generic
|Payment:||Visa, MasterCard, AmEx, Bitcoin
|Delivery:||Regular and express mail service
|Shipping:||Worldwide, including USA, UK, Europe, Canada, Australia
Haloperidol (trade names include Haldol, Decaldol, Haldol Decanoate, Haloperidol Ratiopharm, Haldol Depot, Serenase, Haldol-LA, Halopidol, Hexidol, Serenace, Trancodol) is a typical antipsychotic drug from butyrophenone derivatives pharmacological group. This medication is used for the treatment of schizophrenia, mania in bipolar disorder, tics in Tourette's syndrome, chorea, delirium, vomiting, nausea, agitation, acute psychosis, intractable hiccups, borderline personality disorder, dementia, hallucinations in alcohol withdrawal, for patients with Alzheimer's disease and mild behavioural problems. Haldol is also indicated to control symptoms of hyperactivity, aggression, hyperactive delirium, some severe behavioral disorders in children and adolescents, agitation and confusion associated with cerebral sclerosis, adjunctive treatment of alcohol and opioid withdrawal, therapeutic trial in personality disorders, alcohol-induced psychosis, in veterinary for various kinds of animals, and for the therapy of other disorders and medical conditions of nervous system. Haloperidol works as dopamine D2 receptor antagonist.
Haloperidol Decanoate drugs
Haloperidol Lactate medicines
Lithium Carbonate (Lithobid)
Pharmacological and medical categories:
Typical antipsychotic drugs
Veterinary, pet meds
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AD - Butyrophenone derivatives
N05AD01 - Haloperidol
Dementia in other diseases classified elsewhere - F02
Delirium due to known physiological condition - F05
Mental and behavioural disorders due to use of alcohol - F10
Opioid related disorders - F11
Schizophrenia - F20
Schizotypal disorder - F21
Persistent delusional disorders - F22
Acute and transient psychotic disorders - F23
Schizoaffective disorders - F25
Unspecified nonorganic psychosis - F29
Manic episode - F30
Bipolar disorder - F31
Recurrent depressive disorder - F33
Other anxiety disorders - F41
Borderline personality disorder - F60.3
Attention-deficit hyperactivity disorders - F90
Conduct disorders - F91
Disorders of social functioning with onset specific to childhood and adolescence - F94
Tic disorders - F95
Tourette's disorder - F95.2
Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence - F98
Huntington's disease - G10
Drug-induced chorea - G25.4
Other chorea - G25.5
Alzheimer's disease - G30
Multiple sclerosis - G35
Abnormalities of breathing - R06
Hiccough - R06.6
Nausea and vomiting - R11
Other symptoms and signs involving cognitive functions and awareness - R41
Restlessness and agitation - R45.1
Indications and usage:
Haldol (Haloperidol) is indicated for use in the treatment of schizophrenia.
This medication is also prescribed for the control of tics and vocal utterances of Tourette's Disorder.
Haldol (Haloperidol) tablets are contraindicated in patients with:
Severe toxic central nervous system depression or comatose states from any cause.
Hypersensitivity to this drug - hypersensitivity reactions have included anaphylactic reaction and angioedema.
Dementia with Lewy bodies.
Dosage and administration:
There is considerable variation from patient to patient in the amount of medication required for treatment. As with all drugs used to treat schizophrenia, dosage should be individualized according to the needs and response of each patient. Dosage adjustments, either upward or downward, should be carried out as rapidly as practicable to achieve optimum therapeutic control.
To determine the initial dosage, consideration should be given to the patient's age, severity of illness, previous response to other antipsychotic drugs, and any concomitant medication or disease state. Debilitated or geriatric patients, as well as those with a history of adverse reactions to antipsychotic drugs, may require less Haldol (Haloperidol). The optimal response in such patients is usually obtained with more gradual dosage adjustments and at lower dosage levels.
Parenteral medication, administered intramuscularly in doses of 2 to 5 mg, is utilized for prompt control of the acutelyagitated schizophrenic patient with moderately severe to very severe symptoms. Depending on the response of the patient, subsequent doses may be given, administered as often as every hour, although 4 to 8 hour intervals may be satisfactory. The maximum dose is 20mg/day.
Controlled trials to establish the safety and effectiveness of intramuscular administration in children have not been conducted. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
In general, the symptoms of overdosage by haloperidol would be an exaggeration of known pharmacologic effects and adverse reactions, the most prominent of which would be: severe extrapyramidal reactions, hypotension or sedation. The patient would appear comatose with respiratory depression and hypotension which could be severe enough to produce a shock-like state. The extrapyramidal reactions would be manifested by muscular weakness or rigidity and a generalized or localized tremor as demonstrated by the akinetic or agitans types respectively. With accidental overdosage, hypertension rather than hypotension occurred in a two-year old child. The risk of ECG changes associated with torsade de pointes should be considered.
Since there is no specific antidote, treatment is primarily supportive. A patent airway must be established by use of an oropharyngeal airway or endotracheal tube or, in prolonged cases of coma, by tracheostomy. Respiratory depression may be counteracted by artificial respiration and mechanical respirators. Hypotension and circulatory collapse may be counteracted by use of intravenous fluids, plasma, or concentrated albumin, and vasopressor agents such as metaraminol, phenylephrine and norepinephrine. Epinephrine should not be used. In case of severe extrapyramidal reactions, antiparkinson medication should be administered. ECG and vital signs should be monitored especially for signs of Q-T prolongation or dysrhythmias and monitoring should continue until the ECG is normal. Severe arrhythmias should be treated with appropriate anti-arrhythmic measures.
Increased mortality in elderly patients with dementia-related psychosis
Neuroleptic malignant syndrome (NMS)
Neurological adverse reactions in patients with Parkinson's disease or dementia withlewy bodies
Combined use of Haloperidol and Lithium
Haldol (Haloperidol) should be administered cautiously to patients:
with leukopenia, neutropenia, and agranulocytosis.
with severe cardiovascular disorders, because of the possibility of transient hypotension and/or precipitation of anginal pain. Should hypotension occur and a vasopressor be required, epinephrine should not be used since Haldol may block its vasopressor activity and paradoxical further lowering of the blood pressure may occur. Instead, metaraminol, phenylephrine or norepinephrine should be used.
receiving anticonvulsant medications, with a history of seizures, or with EEG abnormalities, because haloperidol may lower the convulsive threshold. If indicated, adequate anticonvulsant therapy should be concomitantly maintained.
with known allergies, or with a history of allergic reactions to drugs.
receiving anticoagulants, since an isolated instance of interference occurred with the effects of one anticoagulant (phenindione). When Haldol is used to control mania in cyclic disorders, there may be a rapid mood swing to depression. Severe neurotoxicity (rigidity, inability to walk or talk) may occur in patients with thyrotoxicosis who are also receiving antipsychotic medication, including haloperidol.
Information for patients:
Haloperidol pills (Haldol) may impair the mental and/or physical abilities required for the performance of hazardous tasks such as operating machinery or driving a motor vehicle. The ambulatory patient should be warned accordingly.
The use of alcohol with this drug should be avoided due to possible additive effects and hypotension.
Adverse reactions, side effects:
The following adverse reactions of Haloperidol tablets (Haldol) are discussed in more detail in other sections of the labeling:
Use in specific populations:
Since Haldol is excreted in human breast milk, infants should not be nursed during drug treatment with haloperidol.
Safety and effectiveness in pediatric patients have not been established.
Clinical studies of haloperidol did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not consistently identified differences in responses between the elderly and younger patients. However, the prevalence of tardive dyskinesia appears to be highest among the elderly, especially elderly women. Also, the pharmacokinetics of this medication in geriatric patients generally warrants the use of lower doses.
C - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
Brands, generics, trade names:
Agidol - Consern Pharma
Aloperidin - Janssen
Aloperidolo - Galenica Senese Industria Farmaceutica
Apracal - Siegfried Laboratorios
Brain-Rest - Ind-Swift
Decaldol - Polfa Warszawa
Gendol - Gentech Healthcare, Genetics Pharmaceuticals
Haldol - Janssen
Haldol Decanoas - Janssen, DKSH
Haldol Decanoate - Janssen, Ortho McNeil Pharmaceuticals
Haldol Decanoato - Janssen
Haldol Deposito - Janssen
Haldol Depot - Janssen
Haldol-LA - Janssen
Halo - Cristalia Produtos Quimicos Farmaceuticos
Haloper - CT-Arzneimittel
Haloperidol - Fresenius, Janssen, Ratiopharm, Sandoz, Teva
Haloperidol Forte - Gedeon Richter
Haloperidol-LA - Sandoz
Haloperidol Prodes - Kern Pharma
Halopidol - Janssen, Ethnor, Johnson & Johnson
Halosten - Shionogi
Haloxen - Remedica, Goldplus Universal
Hexidol - Torrent Pharmaceuticals
Lodol - Symbiosis Pharmaceuticals
Lodomer - Mersifarma Tirmaku Mercusana
Neupram - Neuropharma
Neurodol - Janssen
Novo-Peridol - Novopharm
Relinase - Reliance Life Sciences
Schizol - K.C. Laboratories
Senorm - Sun Pharmaceutical Industries, Pharmaland
Serenace - Pfizer
Serenase - Janssen
Teva-Haloperidol - Teva
Tiplac - Roemmers Laboratorios
Trancodol - Intas Pharmaceuticals
Uni Haloper - Uniao Quimica Farmaceutica Nacional
APIs used in medicine in combinations with haloperidol:
Here is a list of popular medications containing haloperidol as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
|Trade name of the drug
||Pharmaceutical forms and doses
||Drops; Oral; Haloperidol 0.5 mg / mlDrops; Oral; Haloperidol 2 mg / mlInjectable; Injection; Haloperidol 5 mg / mlSolution; Oral; Haloperidol 2 mg / mlSolution; Oral; Haloperidol 10 mg / mlSolution; Oral; Haloperidol 20 mg / mlTablets; Oral; Haloperidol 0.25 mgTablets; Oral; Haloperidol 0.5 mgTablets; Oral; Haloperidol 1 mgTablets; Oral; Haloperidol 1.5 mgTablets; Oral; Haloperidol 2 mgTablets; Oral; Haloperidol 2.5 mgTablets; Oral; Haloperidol 4 mgTablets; Oral; Haloperidol 5 mgTablets; Oral; Haloperidol 10 mgTablets; Oral; Haloperidol 20 mg
||JanssenDKSHEast West PharmaEurim-PharmEuro RegistratieFamarGlaxoSmithKlineGrunenthalJohnson & JohnsonKRKALexon UKMedcor PharmaceuticalsOrtho McNeil PharmaceuticalsPharmaghreb LaboratoiresServipharmStar PharmaceuticalsTagma PharmaZuellig Pharma
||Capsules; Oral; Haloperidol 0.5 mgDrops; Oral; Haloperidol 2 mg / mlGranules for Suspension; Oral; Haloperidol 10 mg / mlInjectable; Injection; Haloperidol 5 mg / mlInjectable; Injection; Haloperidol 10 mg / mlSuspension; Oral; Haloperidol 2 mg / mlSyrup; Oral; Haloperidol 2 mg / mlTablets; Oral; Haloperidol 0.25 mgTablets; Oral; Haloperidol 0.5 mgTablets; Oral; Haloperidol 0.75 mgTablets; Oral; Haloperidol 1 mgTablets; Oral; Haloperidol 1.5 mgTablets; Oral; Haloperidol 5 mgTablets; Oral; Haloperidol 10 mgTablets; Oral; Haloperidol 20 mg
||PfizerAspenDainippon Sumitomo PharmaHealthcare LogisticsIVAXMetropolis HealthcareP & D PharmaceuticalsPrimal ChemicalPiramal HealthcareRPG Life SciencesSearle PakistanSigma PharmaceuticalsTevaThe Glory MedicinaZuellig Pharma
||Injectable; Injection; Haloperidol 5 mg / mlTablets, Dispersible; Oral; Haloperidol 1.5 mgTablets, Dispersible; Oral; Haloperidol 5 mgTablets, Dispersible; Oral; Haloperidol 10 mgTablets, Dispersible; Oral; Haloperidol 20 mg
Haloperidol main article on Wikipedia: https://en.wikipedia.org/wiki/Haloperidol
Haloperidol compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Haloperidol
Haloperidol Decanoate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Haloperidol-decanoate
Haloperidol Lactate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Haloperidol-lactate
Haloperidol on DrugBank: https://www.drugbank.ca/drugs/DB00502
Haloperidol Decanoate on DrugBank: https://www.drugbank.ca/salts/DBSALT001195
Haloperidol Lactate on DrugBank: https://www.drugbank.ca/salts/DBSALT001232
Haloperidol FAQ on MedlinePlus (revised 07/15/2017): https://medlineplus.gov/druginfo/meds/a682180.html
Haloperidol Injection FAQ on MedlinePlus (revised 07/15/2017): https://medlineplus.gov/druginfo/meds/a615023.html
Haloperidol Mylan tablets drug label info on DailyMed (revised September 27, 2019): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Haloperidol containing drugs on Drugs-About.com: https://drugs-about.com/ing/haloperidol.html
Haloperidol for sale on Pharma Doctor: https://pharma-doctor.com/haloperidol.html
Haloperidol international drug names on Drugs.com: https://www.drugs.com/international/haloperidol.html
Haldol (Haloperidol) injections for immediate release official prescribing information from the U.S. FDA (revised June 2009): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Haldol (Haloperidol) solution for injection prescribing information from Janssen pharmaceutical company (revised September 2018): https://www.janssen-pi.co.uk/en/product-information/7
Haloperidol drug summary from PDR: https://www.pdr.net/drug-summary/Haldol-haloperidol-942
Serenace (Haloperidol) tablets and liquid consumer medicine information from MedSafe (revised March 2015): https://www.medsafe.govt.nz/Consumers/cmi/s/Serenacetabliq.pdf
Haldol Decanoate 50 mg/ml and 100 mg/ml solution for injection package information leaflet from Janssen on Medicines.org.uk (revised April 2020): https://www.medicines.org.uk/emc/files/pil.968.pdf
Trancodol (Haldol generic) 5 mg tablets DT prescribing information from Practo: https://www.practo.com/medicine-info/trancodol-5-mg-tablet-dt-22052
Revised: April 2021
Copyright © 2001 - 2021 QAHDA. All rights reserved.